What is NDC 62332-245?

62332-245 is the product NDC for Fenofibric Acid, Fenofibric acid 135 mg/1 capsule, delayed release, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.

Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Fenofibric Acid?

13 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Fenofibric Acid NDC 62332-245 | National Drug Code

NDC codes

FDA NDC Directory

Product NDC (as listed)62332-245Labeler and product segments. Claims need a package NDC.

Product NDC at billing width62332-0245Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
62332-245-30	6233202453062332024530	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-245-30)Marketed from May 15, 2017
62332-245-90	6233202459062332024590	90 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-245-90)Marketed from May 15, 2017
62332-245-91	6233202459162332024591	1000 CAPSULE, DELAYED RELEASE in 1 BOTTLE (62332-245-91)Marketed from May 15, 2017

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Fenofibric Acid
Generic name (nonproprietary): fenofibric acid
Active ingredients: Fenofibric acid — 135 mg/1
Dosage form: Capsule, Delayed release
Route: Oral
Labeler: Alembic Pharmaceuticals Inc.NDC labeler code 62332
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 208705
Marketing start: May 15, 2017
Listing expires: Dec 31, 2027
Identifiers: Product ID 62332-245_be2cddd4-5895-4bac-b345-4104987661a0SPL ID be2cddd4-5895-4bac-b345-4104987661a0
Pharmacologic class: Peroxisome Proliferator Receptor alpha Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N462332024530 followed by a unit qualifier and the quantity

Package 62332-0245-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

The FDA listing for this product does not reference a label (SPL) set.

About NDC 62332-245

What is NDC 62332-245?: 62332-245 is the product NDC for Fenofibric Acid, Fenofibric acid 135 mg/1 capsule, delayed release, listed with the FDA by Alembic Pharmaceuticals Inc.. It has 3 package NDCs, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Fenofibric Acid.
What is the active ingredient?: Fenofibric acid.
Who is the labeler?: Alembic Pharmaceuticals Inc., NDC labeler code 62332. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Fenofibric Acid?: 13 other product NDCs are listed under this name. See all Fenofibric Acid NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Fenofibric Acid NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Fenofibric Acid	Fenofibric acid 45 mg/1	Capsule, Delayed releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1324	00115-1324-10
Fenofibric Acid	Fenofibric acid 135 mg/1	Capsule, Delayed releaseOral	Amneal Pharmaceuticals of New York LLC	0115-1325	00115-1325-10
Fenofibric acid	Choline fenofibrate 45 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-294	33342-0294-1033342-0294-12
Fenofibric acid	Choline fenofibrate 135 mg/1	Capsule, Delayed releaseOral	Macleods Pharmaceuticals Limited	33342-295	33342-0295-1033342-0295-56
Fenofibric Acid	Fenofibric acid 45 mg/1	Capsule, Delayed releaseOral	Aurobindo Pharma Limited	59651-216	59651-0216-90
Fenofibric Acid	Fenofibric acid 135 mg/1	Capsule, Delayed releaseOral	Aurobindo Pharma Limited	59651-217	59651-0217-90
Fenofibric Acid	Fenofibric acid 45 mg/1	Capsule, Delayed releaseOral	Leading Pharma, LLC	69315-281	69315-0281-09
Fenofibric Acid	Fenofibric acid 135 mg/1	Capsule, Delayed releaseOral	Leading Pharma, LLC	69315-282	69315-0282-09
Fenofibric Acid	Fenofibric acid 135 mg/1	Capsule, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-245	46708-0245-3046708-0245-9046708-0245-91
Fenofibric Acid	Fenofibric acid 45 mg/1	Capsule, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-244	46708-0244-3046708-0244-9046708-0244-91

All 14 Fenofibric Acid NDCs

Other NDCs under ANDA 208705

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 208705
Product	Strength	Form · route	Labeler	Product NDC
Fenofibric Acid	Fenofibric acid 45 mg/1	Capsule, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-244
Fenofibric Acid	Fenofibric acid 135 mg/1	Capsule, Delayed releaseOral	Alembic Pharmaceuticals Limited	46708-245
Fenofibric Acid	Fenofibric acid 45 mg/1	Capsule, Delayed releaseOral	Alembic Pharmaceuticals Inc.	62332-244